発作のある小児および青年におけるブリバラセタムの安全性と忍容性を試験する研究

基本情報

NCT ID: NCT04715646
ステータス: 募集中
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 70
治験依頼者名: UCB Pharma

概要

The purpose of the study is to evaluate the long-term safety and tolerability of brivaracetam.

対象疾患

Epilepsy

介入

Brivaracetam(DRUG)

依頼者（Sponsor）

ユーシービージャパン(INDUSTRY)

実施施設 (19)

Ep0156 804

Tokyo, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 811

Nagoya, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 812

Niigata, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 800

Gifu, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 809

Shimotsuke, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 815

Kodaira-shi, Japan(RECRUITING)

Ep0156 805

Sapporo, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 816

Sendai, Japan(RECRUITING)

Ep0156 817

Osaka, Japan(RECRUITING)

Ep0156 807

Hiroshima, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 819

Ōmura, Japan(RECRUITING)

Ep0156 806

Kyoto, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 802

Yonago, Japan(COMPLETED)

Ep0156 813

Kōshi, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 818

Ōbu, Japan(RECRUITING)

Ep0156 810

Yokohama, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 803

Bunkyō City, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 808

Chūō, Japan(ACTIVE_NOT_RECRUITING)

Ep0156 814

Shizuoka, Japan(RECRUITING)